FONDAPARINUX for Atrial fibrillation: Side Effects & Safety Data
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
There are 78 adverse event reports in the FDA FAERS database where FONDAPARINUX was used for Atrial fibrillation.
Most Reported Side Effects for FONDAPARINUX
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 356 | 16.0% | 36 | 195 |
| Haematoma | 168 | 7.5% | 21 | 137 |
| Anaemia | 159 | 7.1% | 19 | 124 |
| Drug ineffective | 117 | 5.3% | 15 | 60 |
| Pulmonary embolism | 97 | 4.4% | 11 | 50 |
| Haemorrhage | 89 | 4.0% | 25 | 36 |
| Cerebral haemorrhage | 78 | 3.5% | 38 | 43 |
| Heparin-induced thrombocytopenia | 76 | 3.4% | 8 | 36 |
| Thrombocytopenia | 72 | 3.2% | 11 | 32 |
| Thrombosis | 71 | 3.2% | 7 | 27 |
| Shock haemorrhagic | 67 | 3.0% | 19 | 41 |
| Pruritus | 61 | 2.7% | 1 | 42 |
| Deep vein thrombosis | 56 | 2.5% | 5 | 20 |
| Dyspnoea | 54 | 2.4% | 8 | 37 |
| Melaena | 53 | 2.4% | 4 | 46 |
Other Indications for FONDAPARINUX
Product used for unknown indication (453)
Thrombosis prophylaxis (348)
Deep vein thrombosis (166)
Anticoagulant therapy (155)
Pulmonary embolism (115)
Thrombosis (71)
Acute coronary syndrome (63)
Off label use (57)
Acute myocardial infarction (54)
Prophylaxis (54)
Other Drugs Used for Atrial fibrillation
RIVAROXABAN (52,584)
DABIGATRAN ETEXILATE (20,492)
APIXABAN (10,500)
AMIODARONE (9,083)
WARFARIN (8,680)
EDOXABAN (3,855)
ASPIRIN (2,993)
DOFETILIDE (2,439)
PRADAXA (2,325)
METOPROLOL (1,542)